Enfusion

Enfusion OCF/Debt

Delisted

The Operating Cash Flow to Debt Ratio of Enfusion (ENFN) as of Nov 7, 2026 is 1.69 %. In the previous year, Operating Cash Flow to Debt Ratio was 44.43 % — a change of -96.20% (lower).

OCF/Debt

1.69 %

YoY

-96.20%

Last updated:

Operating Cash Flow to Debt Ratio of Enfusion is 2020 1.69 % . Operating Cash Flow to Debt Ratio of Enfusion was 2019 44.43 % . It decreases by -96.20% lower compared to the previous year.

The Enfusion OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2019
44.43 USD
Jan 1, 2020
1.69 USD
The Enfusion OCF/Debt history
YEAROCF/DebtYoY
1.69 %-96.20%
44.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Operating Cash Flow to Debt Ratio of Enfusion is 1.69 % in 2020.

Operating Cash Flow to Debt Ratio of Enfusion changed from 44.43 % to 1.69 %, representing a -96.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Enfusion since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Enfusion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Enfusion

All Key Metrics — Enfusion